Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Daniel Grosu

Premium

Illumina has appointed Daniel Grosu as Chief Medical Officer, a newly created position at the company. Grosu will play a key role in building Illumina’s diagnostic capabilities through collaborations with regulatory agencies, internal product development teams, and Illumina’s CLIA-certified clinical laboratory, the company said.

Prior to joining Illumina, Grosu was group director of clinical science and clinical and medical affairs at Ortho-Clinical Diagnostics. He also was previously the director and leader of global clinical development and diagnostic imaging at Bayer Healthcare Pharmaceuticals. Grosu also has worked for Siemens Medical Solutions.